PAR
Click for more information
0.00% 27.5¢ paradigm biopharmaceuticals limited..

Ann: PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL, page-20

  1. MisterMister
    572 Posts.
    lightbulb Created with Sketch. 55
    clock Created with Sketch.
    16/12/21
    16:25
    Post #: 58344265
    Did PAR just re-do and pay for a study which someone else has done (and reasonably recently?). Looks like the real winners here are their CRO's. Gravy train going full tilt.
    PAR Price at posting: $1.91 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $96.19M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 1322 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 2400 1
View Market Depth
Last trade - 09.50am 11/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.